English (United Kingdom)Bulgarian (Български)

esberitox

Description

Esberitox® N

Supporting the immune defence of the organism

esberitox esberitox esberitox

ThujaeЕchinaceaBaptisiae

with active substances from the nature

Esberitox® N helps for:

  • Prophylactics
  • Faster recovery
  • Reduced severity of the symptomatology
  • Reduced frequency of recurrences

Application:

  • Therapy of acute & chronic respiratory tract infections (of viral or bacterial origin)
  • Concomitant therapy for
    an antibiotic treatment
    Concomitant therapy foran antibiotic treatment
  • Preventive – before flu season or twice a year
  • Bacterial skin infections
  • Leucopoenia after radiation
  • In parallel with cytostatic treatment
  • Susceptibility to infections

Dosage:

breast-fed children:
3 х 10 drops or 3 х 1 tabl. daily
children under 6:
3 х 15 drops or 3 х 1-2 tabl. daily
children under 12:
3 х 25 drops or 3 х 2 tabl. daily
adults:
3 х 50 drops or 3 х 3 tabl. daily

Esberitox® N is product №1 in Germany for 2008 in the group of the immunomodulators!

esberitox

Summary


For centuries, preparations from the purple coneflower have been used for the stimulation of the immune system against the common cold. Esberitox ® mono contains the aerial parts of the coneflower as standardized active substance.

In case of recurrent (frequent) respiratory tract infections the immunoresistance can be sensibly strengthened with this medicine.


Product Information of Esberitox ® mono Tablets

Dear patient!

Please read the following product information carefully. It contains important information about the application of this herbal drug. If you have any questions please consult your treating physician or pharmacist.

Active Substance:

Dry extract of pressed purple coneflower juice

Composition:

1 tablet contains:
Medicinally active components:
Dry extract (corresponding to 1 ml pressed juice) from purple coneflower foliage (Echinaceae purpureae herba) 50 - 60 mg

Other ingredients:
Ascorbic acid, cellactose, potato starch, lactose, magnesium stearate,
saccharine/sodium, maltodextrin, sugar based coloring agent E 150

Pharmaceutical Form and Content:

Original package of 50 tablets (N2)
Original package of 100 tablets (N3)

Substance or Indication Group/ Mode of Action:

Immunomodulator for the increase in the body's immunoresistance.

Pharmaceutical Enterprise

Schaper & Brummer GmbH & Co. KG, 38251 Salzgitter, Germany
Phone +49 (53 41) 3 07-0, facsimile +49 (53 41) 3 07-124
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.schaper-bruemmer.com

Indications:

Supporting therapy of recurrent (frequently recurring) infections of the respiratory tract.

Contraindications:

When not to use Esberitox ® mono tablets:
In case of a hypersensitivity against one of the active substances or excipients or against composite flowers. For fundamental reasons do not use in case of progredient (continuing) systemic illnesses such as tuberculosis, leucosis (leukaemia), collagenoses (inflammable diseases of the connective tissue), multiple sclerosis, AIDS diseases, HIV-infection and other autoimmune diseases (antibody formation against body-own tissue).

Interactions:

Which other drugs influence the effect of Esberitox ® mono tablets?
None known.

Dosage Directions, Route and Duration of Administration:

The following information applies, unless you have received different instructions from your treating physician for the administration of Esberitox ® mono tablets. Please adhere to theses directions, as otherwise Esberitox ® mono tablets cannot work correctly!

How often and how many Esberitox ® mono tablets should you take?
Adults and children as of the age of 4 years take 2 to 3 tablets 3 times daily; this corresponds to a daily dose of 6 to 9 tablets.
Children age 1 to 4 years take 1 tablet 3 times daily.

How and when should you take Esberitox ® mono tablets?
Take the tablets in the morning, at noon and in the evening unchewed with some liquid.

How long should you take Esberitox ® mono tablets?
In case of recurrent respiratory tract infections Esberitox ® mono tablets should be taken a few days beyond the disappearance of symptoms, however, not longer than 8 weeks.

Side Effects :

Which side effects can occur during the administration of Esberitox ® mono tablets?

In individual cases hypersensitivity reactions can occur. For drugs with preparations from coneflowers rashes, itching, rarely facial swelling, shortage of breath, vertigo and a drop in blood pressure have been observed. If you perceive any side effects in yourself, which have not been described in this package insert, please inform your treating physician or pharmacist of these.

Warnings and Information Regarding Drug Stability:

The expiration date of this package is imprinted on the side flap. Please do not use after this date.

Status of the Information :

April 2001

This drug is being marketed as per the German legal transition status regulations. The official investigation of pharmaceutical quality, effectiveness and safety has not been concluded yet.

Keep drugs out of reach of children!

Characteristics :

Esberitox ® mono tablets contain active substances from the purple coneflower. These activate the body-own defense system (immune system) in humans and increase the resilience of the entire organism. Esberitox ® mono tablets can support overcoming infections of viral or bacterial origin. In case of viral respiratory tract infections the stabilization of the immune system with Esberitox ® mono tablets is particularly important, because duration and severity as well as the frequency of viral respiratory infections are influenced to a great extent by the capacity of the body-own defense system.

If the immune system has been weakened by chronic illnesses, stress, preceding infections or surgery or certain medications, a stabilization of the immune system is sensible. Esberitox ® mono tablets frequently clearly reduce the frequency of infections due to a temporarily (transitory) weakened immune system.